© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Sydney Jennings
Articles
Does Intranasal Insulin Reach Critical Brain Areas Linked to Memory and Cognition?
August 11, 2025
Insulin delivered via nasal spray in this first-in-human PET imaging study was observed in 11 key brain areas relevant to cognitive decline, validating a new research avenue.
FDA Accepts Gepotidacin for Priority Review for the Treatment of Uncomplicated Urogenital Gonorrhea
August 11, 2025
FDA accepts priority review of gepotidacin for uncomplicated urogenital gonorrhea, with phase 3 data showing non-inferiority to standard injectable therapy.
Investigational Oral IL-23 Receptor Antagonist Icotrokinra Improves Skin Clearance in Psoriasis in Phase 3 Study
August 11, 2025
The oral peptide that selectively targets IL-23 offers a novel approach to quelling the inflammatory process that underlies plaque psoriasis.
GLP-1 RAs Beat Metformin for Dementia Prevention in T2D: Daily Dose
August 11, 2025
Your daily dose of the clinical news you may have missed.
Are the GLP-1 Agonists "Forever Drugs?" It's an Open Question, According to Jonathan Bonnet, MD, MPH
August 08, 2025
The obesity and lifestyle medicine specialist says while research on the question continues, a focus on optimizing nutritional health during treatment is essential.
The TikTok Doc Is In: But Will Your Patient Trust the Diagnosis?
August 08, 2025
Health information permeates social media platforms exposing Americans to advice, even when they don't want it. The good news? Not many trust it!
How Physicians Can Strengthen Vaccine Confidence During National Immunization Awareness Month
August 08, 2025
Board-certified family physician Sarah Sams, MD, urges physicians to actively engage their communities to build vaccine confidence and combat misinformation.
Excess Intake of Ultraprocessed Foods is Tied to Higher Cardiometabolic Risk, AHA Advisory Panel Says
August 08, 2025
The Advisory Panel laid out 4 priority actions for clinicians, policy makers, and industry.
Novel Plasma Assays That Selectively Detect Tau Characteristics Will Refine Clinical Study of Alzheimer Disease
August 08, 2025
The 2 new plasma assays to enhance Alzheimer’s disease research will support disease staging, predicting disease progression, and monitoring treatment outcome.
FDA Approves Finerenone for Treatment of Heart Failure With LVEF ≥40%: Daily Dose
August 08, 2025
Your daily dose of the clinical news you may have missed.